Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar control and reduced cardiovascular risk factors,…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/novo-nordisks-obesity-pill-shows-cardiovascular-benefits-2025a1000uil?src=rss
Author :
Publish date : 2025-11-05 13:17:00
Copyright for syndicated content belongs to the linked Source.
